Specialties & Service

Orbital & Ophthalmic Oncology

Oncology & Orbital and Oculoplastic Division is a leading team in field. faculty specializes in intraocular tumors and diseases of the eyelids and orbit, including trauma, tumors, inflammation, congenital defects, eyelid malpositions, thyroid eye (Graves') diseases, reconstructive and cosmetic surgery, and disorders of the lacrimal system. Comprehensive evaluations and personalized therapies are provided for patients with the above disorders. we offer the latest techniques, including intra-arterial chemotherapy, intravitreal chemotherapy, transpupillary thermotherapy, brachytherapy, proton therapy, DSA, immunotherapy, local injection, and et al.

 

Faculty & Staff

Jiang Qian, MD, PhD, Director  

Rui Zhang, MD, PhD

YiFei Yuan, MD, PhD

JinWei Cheng, MD, PhD

YanQing Zhang, MD, PhD

Hui Ren, MD, PhD


  • Intraocular Tumor Center
  • Thyroid eye disease (TED)

The Intraocular Tumor Center focuses on various tumors that originate or metastasize into the eye. We and our multidisciplinary team (composed of Pediatric Oncology, Neurosurgery Department, Intervention Department, Radiation Department and Genetic Counseling specialists) provide comprehensive care in treatment, post-treatment services and clinical trials.

As one of the largest eye cancer center in China, we've been committed to treat intraocular tumors for more than sixty years. We are particularly working on the treatment of retinoblastoma and uveal melanoma, using cutting-edge treatments and exploring the newest treatment techniques, including proton and heavy ion therapy, intra-aterial chemotherapy, intravitreal chemotherapy, brachytherapy, transpupillary thermotherapy, etc. This allows physicians design individualized therapeutic strategies to achieve the best treatment outcome.

排班:

Intraocular tumor clinic     Friday 8:00 - 11:30 ; Saturday 8:00 - 11:30

 

Expert Service:

Professor Jiang, Qian      Monday 8:00 - 11:30 ;  Wednesday 8:00 - 11:30

Professor  Rui, Zhang     Monday 8:00 - 11:30 ;  Thursday 8:00 - 11:30    

Professor  Kang, Xue     Monday 13:30 - 16:30; Friday 8:00 - 11:30

Professor  Hui, Ren       Monday 13:30 - 16:30 ;  Wednesday 13:30 - 16:30


Thyroid eye disease (TED) is one of the most common orbital diseases in adults. The common symptoms include exophthalmos, eyelid retraction, eye position deviation, eye movement disorder, which seriously affect the appearance and quality of life. The severe complications such as exposure keratitis and compressive optic neuropathy can cause visual acuity decline and even blindness. Therefore, it is necessary to standardize and individualize the diagnosis and treatment strategy. The Thyroid Eye Disease Center will provide more convenient and efficient medical support for TED patients.

Our team is one of the earliest teams to carry out the clinical and fundamental research of TED in China. After nearly a decade of development, Professor Qian Jiang has continuously improved the standardized diagnosis and treatment strategy of TED in China. He adheres to the concept of accurate and individualized treatment, pursues the treatment effect of small incision and minimally invasive, and maximizes the improvement of visual function and appearance. Professor Qian Jiang, together with his team, has reported the treatment achievements of TED in various international conferences and has been highly praised by experts at home and abroad.

Our team has published nearly 20 SCI articles related to TED, obtained 5 grants supported by the National Natural Science Foundation of China and the Shanghai Natural Science Foundation, and has applied for 2 patents of diagnosis and treatment strategy in the field of TED. Our team has received strong support from ophthalmology department, endocrinology department and radiotherapy department of Changzheng Hospital, Huashan Hospital, Ruijin Hospital, Longhua Hospital, Shanghai General Hospital and Shanghai Sixth People's Hospital, so as to escort multidisciplinary consultation and personalized treatment of TED patients.